Products

Browse our products

Want to know more?
Reach out to our team to know more about the product or how to purchase
 
Get more information

Fujirebio INNO-LiPA® CFTR 19

Analysis of 35 CFTR mutations and wild types, plus CBAVD-related Tn polymorphism

INNO-LiPA CFTR is a multiparameter line probe assay, based on the reverse hybridization principle, for the simultaneous detection and identification of 35 cystic fibrosis-related mutations and their wild-type sequences in human whole blood, dried blood spots, and buccal brush samples.

In addition, probes for the identification of the Tn polymorphism within intron 8 are included.

For the detection and identification of all 35 mutations, the INNO-LiPA CFTR 19 and INNO-LiPA CFTR 17+Tn Update kits are required.

Features & Benefits

  • Two strips replace multiple testing.
  • The INNO-LiPA CFTR provides probes for the 35 most frequent CFTR-related mutations worldwide.
  • The combination of the 2 strips also covers the panel of CFTR mutations recommended by the ACMG/ACOG (23 mutations).
  • Analysis of both the mutant and the wild-type sequences demonstrates homo- or heterozygosity for each tested mutation, allowing the discrimination between carrier status and patients.
  • The test is fast and easy to perform, offers quick visual interpretation, and full results are obtained within one working day.
  • Fully automated processing of the strips is possible using Auto-LiPA™ 48 and AutoBlot 3000H.
  • Objective, automated reading and interpretation of the strips is possible using LiRAS® for LiPA Cystic Fibrosis.
  • Manual interpretation possible.

For more information, visit Fujirebio.com.

Related Products

    DISCLAIMER
    PROFESSIONAL CERTIFICATION. THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
    Getz Healthcare shares your commitment to achieving the best possible patient outcomes by connecting healthcare professionals with the finest medical technologies and supplies in the market.
    By continuing, you are acknowledging that you are a registered healthcare professional with a valid certification.

    No, I Disagree